click below
click below
Normal Size Small Size show me how
Group 1
Paramedic Drugs group 1
| Question | Answer |
|---|---|
| Etomidate - Generic | Etomidate |
| Etomidate - Trade Name | Amidate |
| Etomidate - Classification | Sedative, Anesthetic |
| Etomidate - Action | Rapidly induces anesthesia by depressing the brain stem reticular system. |
| Etomidate - Indication | Facilitate anesthesia for Endotracheal Intubation |
| Etomidate - Contraindication | None |
| Etomidate - Side Effects | Apnea, Hypotension, Hypertension, Larynygospasms, Fasciculation, Tachycardia, Bradycardia, Arrhythmias. |
| Etomidate - Routes | IV Push |
| Etomidate - Dosage | 0.3 mg/kg IV |
| Etomidate - Clinical Considerations | Used in conjunction with paralytics; Duration: 3-8 Minutes, Will need to resedate. |
| Succinylcholine - Generic | Succinylcholine |
| Succinylcholine - Trade | Quelicin |
| Succinylcholine - Classification | Depolarizing Paralytic; Neuromuscular blocking agent. |
| Succinylcholine - Action | Binds to acetylcholine receptors at nerve endings of skeletal muscles to block any response to stimulus, Causes complete relaxation. |
| Succinylcholine - Indication | Induce paralysis for Endotracheal Intubation |
| Succinylcholine - Contraindication | Narrow angle glaucoma, Penetrating Eye Injuries, Inability to intubate the patient. CAUTION - Crush injuries, Increased ICP, Renal failure, Neuromuscular disorders. |
| Succinylcholine - Side Effects | Apnea, Respiratory Depression, Fasciculation, ICP Increase, Hyperthermia, Asystole, Increased intraocular pressure, bradycardia, muscle pain, hyperkalemia, BP Changes, Dysrhythmias. |
| Succinylcholine - Routes | IV, IM, IO |
| Succinylcholine - Doseage | Adult: 1.5 mg/kg IV, Pediatrics: 1-2 mg/kg IV/IO; Can repeat if inadequate relaxation. Lasts 5-16 minutes. |
| Succinylcholine - Clinical Considerations | Have sedation available; Have atropine ready for bradycardia; Avoid in burn patients more than 48 hours old; Chronic neuromuscular disease, ESRD, Situations where hyperkalemia is likely. |
| Ketamine - Generic | Ketamine |
| Ketamine - Trade Name | Ketalar |
| Ketamine - Classification | Sedative, Analgesic disassociate anesthetic. |
| Ketamine - Action | Blocks pain receptors; Minimizes spinal cord activity; Affects pathway of the brain between thalamus and limbic systems. |
| Ketamine - Indication | Excited delirium, Pain management, Procedural sedation. |
| Ketamine - Contraindication | Hypersensitivity, Pregnant / Breast Feeding PT's, Conditions where HTN can be hazardous. |
| Ketamine - Side Effects | HTN, Dysarrhythmias, Bronchodilation, Respiratory Depression |
| Ketamine - Routes | IV / IO |
| Ketamine - Dosage | Adults / Pediatric: 1-2 mg/kg over 1-2 minutes. Onset: 30 seconds; Duration: 5-10 minutes. |
| Ketamine - Clinical Considerations | Enhances: Opiates, Barbiturates, non-depolarizing neuromuscular blocking agents; PT's may experience emergence reaction after full duration of medications effect. |
| Norcuron - Generic | Norcuron |
| Norcuron - Trade Name | Vercuronium |
| Norcuron - Classification | Paralytic, Non-depolarizing skeletal muscle paralytic. |
| Norcuron - Action | Blocks cholinergic receptors and prevents acetylcholine from binding to receptors. Blocks depolarizing and paralyzing the muscle. |
| Nourcron - Indication | Facilitate RSI |
| Nourcron - Contraindication | Inability to Intubate |
| Norcuron - Side Effects | Apnea, Histamine release, Hypotension, Flushing, Tachycardia. |
| Norcuron - Routes | IV |
| Norcuron - Dosage | Adult: 0.1 mg/kg; Pediatrics: 0.25 mg/kg IV / IO |
| Norcuron - Clinical Consideration | Paralyzed 25/30 minutes; Avoid in: Chronic neuromuscular disease. (Ex. Muscular Dystrophy) |